On June 14, 2017, Athenex celebrated its initial public offering (IPO) at the Nasdaq MarketSite in Times Square.
Recent News
Our Science
We are focused on discovering and developing novel therapies for treating cancer and addressing unmet medical needs.
Learn moreJoin Our Team
As the Company grows, we are always looking to add talented professionals to join the Athenex family.
Learn moreOther Highlights
Athenex is building a 409,000 square foot manufacturing facility in Dunkirk, NY, with support from New York State.